2026 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
India
India’s biopharma landscape is proving its model with licensing wins, tech-driven global capability centers, and a sharpened focus on public health. The country is positioning itself as both a hub for innovation and a partner in solving global healthcare gaps.
Public Health And Innovation: Addressing Gaps, Pharma’s Role
Expert panel including Ashok Venkitaraman, director of the Cancer Science Institute of Singapore, discusses public health challenges and innovations to help address these. Long-acting drugs, intercepting cancer early and “design thinking” by ophthalmologists in India were among the talking points.